학술논문
Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial
Document Type
Article
Author
Fürstenau, Moritz; Giza, Adam; Weiss, Jonathan; Kleinert, Fanni; Robrecht, Sandra; Franzen, Fabian; Stumpf, Janina; Langerbeins, Petra; Al-Sawaf, Othman; Simon, Florian; Fink, Anna-Maria; Schneider, Christof; Tausch, Eugen; Schetelig, Johannes; Dreger, Peter; Böttcher, Sebastian; Fischer, Kirsten; Kreuzer, Karl-Anton; Ritgen, Matthias; Schilhabel, Anke; Brüggemann, Monika; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Cramer, Paula
Source
In Blood 18 July 2024 144(3):272-282
Subject
Language
ISSN
0006-4971